Session TUAB01 – Antiretroviral strategies | Watch the video
This oral abstract session focussed mainly on HIV treatment simplification, using dolutegravir-based regimens. Two studies looked at dolutegravir monotherapy as a switch strategy for patients stable on triple therapy.
Bictegravir in a single-tablet regimen, which can be dosed without food, will become another treatment option available to HIV prescribers. It is safe and effective to switch patients from Dolutegravir/Abacavir/3TC.
Privacy | Terms & Conditions | Contact Us | Copyright
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine | ABN 48 264 545 457 | CFN 17788 | Copyright © 2020. ASHM